China Universal Asset Management Company’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187K Sell
5,162
-473
-8% -$16.2K 0.01% 359
2026
Q1
$186K Buy
5,635
+484
+9% +$20.5K 0.01% 358
2025
Q4
$238K Sell
5,151
-371
-7% -$15.5K 0.02% 333
2025
Q3
$193K Sell
5,522
-934
-14% -$32.5K 0.02% 339
2025
Q2
$191K Buy
6,456
+141
+2% +$4.02K 0.02% 315
2025
Q1
$189K Sell
6,315
-523
-8% -$16K 0.02% 318
2024
Q4
$196K Buy
6,838
+642
+10% +$21.2K 0.02% 324
2024
Q3
$239K Buy
6,196
+2,352
+61% +$83.9K 0.03% 284
2024
Q2
$124K Sell
3,844
-2,276
-37% -$78.9K 0.02% 288
2024
Q1
$238K Buy
6,120
+2,344
+62% +$82K 0.03% 272
2023
Q4
$116K Buy
3,776
+2,877
+320% +$72.1K 0.02% 265
2023
Q3
$20.1K Buy
899
+445
+98% +$10.1K 0.01% 297
2023
Q2
$9.76K Sell
454
-8
-2% -$182 ﹤0.01% 320
2023
Q1
$11.1K Buy
462
+121
+35% +$3.21K ﹤0.01% 286
2022
Q4
$7.91K Buy
341
+21
+7% +$423 ﹤0.01% 248
2022
Q3
$5K Buy
+320
New +$5.64K ﹤0.01% 269

Other funds holding COLL

China Universal Asset Management Company's COLL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Collegium Pharmaceutical (COLL) stake by 8.4% in Q2 2026, selling an estimated $16.2K and leaving 5,162 shares worth $187K. The position accounts for 0.01% of the portfolio, ranked #359.

China Universal Asset Management Company first reported a position in COLL in Q3 2022 and has held it in 16 quarters since. The position peaked at $239K in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • China Universal Asset Management Company held 5,162 shares of Collegium Pharmaceutical worth $187K as of Q2 2026.
  • China Universal Asset Management Company sold 473 Collegium Pharmaceutical shares in Q2 2026, an estimated $16.2K.
  • Collegium Pharmaceutical made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #359 holding.
  • China Universal Asset Management Company first reported a position in Collegium Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Collegium Pharmaceutical position peaked at $239K in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.